Company Filing History:
3 out of 12 
1 out of 832,843 Years Active: 2021-2024
Title: Fred Hamlin: Innovator in Drug Delivery Systems
Introduction
Fred Hamlin is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of drug delivery systems, holding a total of 4 patents. His work focuses on enhancing the efficiency and usability of inhalation devices.
Latest Patents
One of his latest patents is for an aerosol delivery system that features an electronically controlled, motor-driven, breath-actuated metered dose inhaler. This innovative inhaler is designed to deliver aerosolized medicament or other matter to users effectively. It includes a base housing with a motor-driven actuator and a removable aerosol cartridge. The inhaler can be paired with a smartphone or other client computing devices to offer additional functionalities, such as instructional information, dosage tracking, and alerts for users.
Another significant patent involves drug delivery systems that isolate and desiccate portions of a drug delivery tract. This system aims to reduce water vapor content within the inhaler. The metered dose inhaler allows aerosolized medicament to be discharged into an inhalation passageway for user inhalation. It features a seal member that isolates the discharge passageway from the inhalation passageway during inactivity, enhancing the device's efficiency.
Career Highlights
Fred Hamlin has worked with Pearl Therapeutics, Inc., where he contributed to the development of advanced inhalation technologies. His expertise in drug delivery systems has positioned him as a key player in the industry.
Collaborations
Fred has collaborated with notable professionals in the field, including Matthew S. Ferriter and Jill Sherwood. Their combined efforts have led to advancements in inhalation technology and drug delivery systems.
Conclusion
Fred Hamlin's innovative work in aerosol delivery systems and drug delivery technologies has made a significant impact on the medical field. His patents reflect a commitment to improving patient care through advanced inhalation devices.